These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 836758)

  • 1. Sensitivity to cytotoxic agents of the EMT6 tumour in vivo: tumour volume versus in vitro plating. 1. Cyclophosphamide.
    Twentyman PR
    Br J Cancer; 1977 Feb; 35(2):208-17. PubMed ID: 836758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sensitivity to cytotoxic agents of the EMT6 tumor in vivo. Comparative response of lung nodules in rapid expotential growth and of the solid flank tumour.
    Twentyman PR; Bleehen NM
    Br J Cancer; 1976 Mar; 33(3):320-8. PubMed ID: 57788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Stephens TC; Peacock JH
    Br J Cancer; 1977 Sep; 36(3):313-21. PubMed ID: 921888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity to 1,3-bis(2-chloroethyl)-1-nitrosourea and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea of the EMT6 tumor in vivo as determined by both tumor volume response and in vitro plating assay.
    Twentyman PR
    Cancer Res; 1978 Aug; 38(8):2395-400. PubMed ID: 667838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental chemotherapy studies: intercomparison of assays.
    Twentyman PR
    Br J Cancer Suppl; 1980 Apr; 4():279-87. PubMed ID: 7000124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose cyclophosphamide treatment of human oat cell xenografts in immune deprived mice.
    Evans BD; Smith IE; Millar JL
    Br J Cancer; 1983 Feb; 47(2):215-9. PubMed ID: 6297529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic response of human lung tumour xenografts to cyclophosphamide.
    Mattern J; Jaeger S; Wayss K; Volm M
    Anticancer Res; 1982; 2(6):355-8. PubMed ID: 7168553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
    Ono K; Shrieve DC
    J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of nitrosourea resistant sublines of Lewis lung tumour following MeCCNU treatment in vivo.
    Stephens TC; Adams K; Peacock JH
    Br J Cancer; 1986 Feb; 53(2):237-45. PubMed ID: 3954945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of growth delay and cell survival as end-points of tumour response following treatment with combinations of cytotoxic agents.
    Stephens TC; Peacock JH
    Br J Cancer Suppl; 1980 Apr; 4():288-93. PubMed ID: 6932938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of cyclophosphamide cytotoxicity in vivo by the benzamide analogue pyrazinamide.
    Horsman MR; Chaplin DJ
    Br J Cancer; 1994 Apr; 69(4):648-54. PubMed ID: 8142253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CB 1954 revisited. II. Toxicity and antitumour activity.
    Workman P; Morgan JE; Talbot K; Wright KA; Donaldson J; Twentyman PR
    Cancer Chemother Pharmacol; 1986; 16(1):9-14. PubMed ID: 3940225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell survival in B16 melanoma after treatment with combinations of cytotoxic agents: lack of potentiation.
    Stephens TC; Peacock JH; Steel GG
    Br J Cancer; 1977 Jul; 36(1):84-93. PubMed ID: 889685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The proliferative state of clonogenic cells in the Lewis lung tumour after treatment with cytotoxic agents.
    Bateman AE; Steel GG
    Cell Tissue Kinet; 1978 Sep; 11(5):445-54. PubMed ID: 569015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem-cell survival and tumor control in the Lewis lung carcinoma.
    Steel GG; Adams K
    Cancer Res; 1975 Jun; 35(6):1530-5. PubMed ID: 1169108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of "potentially lethal damage" in EMT6 mouse tumour cells treated with bleomycin either in vitro or in vivo.
    Twentyman PR; Bleehen NM
    Br J Cancer; 1975 Oct; 32(4):491-501. PubMed ID: 55271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of normal mouse marrow and RIF-1 tumour to hyperthermia combined with cyclophosphamide or BCNU: a lack of therapeutic gain.
    Honess DJ; Bleehen NM
    Br J Cancer; 1982 Aug; 46(2):236-48. PubMed ID: 6758828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinations of cytotoxic agents that have less than expected toxicity on normal tissues in mice.
    Millar JL; McElwain TJ
    Antibiot Chemother (1971); 1978; 23():271-82. PubMed ID: 646327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.
    Struck RF; Dykes DJ; Corbett TH; Suling WJ; Trader MW
    Br J Cancer; 1983 Jan; 47(1):15-26. PubMed ID: 6821629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of mice with metastatic osteosarcoma treated by cyclophosphamide or radiotherapy.
    Shaeffer J; El-Mahdi AM; Constable WC
    Cancer Res; 1975 Dec; 35(12):3596-8. PubMed ID: 1059504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.